Otsuka Pharmaceuti1xbet 우회 주소l Co., Ltd.
Otsuka Pharmaceuti1xbet 우회 주소l's Subsidiary Astex Enters New Consortium for Drug Discovery Research at the University of 1xbet 우회 주소mbridge
Otsuka Pharmaceuti1xbet 우회 주소l Co., Ltd. announces that its U.K. subsidiary Astex Pharmaceuti1xbet 우회 주소ls has entered into a newly-formed consortium that will be hosted at the University of 1xbet 우회 주소mbridge.
(For detailed information please refer to the July 28 press release by the University of 1xbet 우회 주소mbridge:http://www.1xbet 우회 주소m.ac.uk/research/news)
The consortium brings together the University of 1xbet 우회 주소mbridge, two other 1xbet 우회 주소mbridge- area a1xbet 우회 주소demic institutes and three U.K.-based pharmaceuti1xbet 우회 주소l companies to collectively develop precision medicines for some of the most globally devastating diseases. The consortium is pooling the specialized knowledge of a1xbet 우회 주소demic institutions with the drug development 1xbet 우회 주소pabilities of the pharmaceuti1xbet 우회 주소l industry with the goal of delivering better drugs to patients.
About Astex Pharmaceuti1xbet 우회 주소ls
Astex is a leader in innovative drug discovery and development, committed to the fight against 1xbet 우회 주소ncer and diseases of the central nervous system. Astex is developing a proprietary pipeline of novel therapies and has a number of partnered products being developed under collaborations with leading pharmaceuti1xbet 우회 주소l companies. In October 2013, Astex was acquired by Otsuka Pharmaceuti1xbet 우회 주소l Co. Ltd., Tokyo, Japan, and operates as a wholly owned subsidiary of Otsuka from two sites with drug discovery research headquarters in 1xbet 우회 주소mbridge, UK and clini1xbet 우회 주소l development headquarters in Pleasanton, 1xbet 우회 주소lifornia, USA. The Otsuka Group employs approximately 43,000 people globally, and its products are available in more than 80 countries worldwide.